Health

Results: 133-144 of 8081

PDUFA Action Date for Hansa Biopharma's Imlifidase BLA Set for December 19, 2026

PR Newswire associated0

Altruist Biologics Launches Altru-CON™ High-Concentration Formulation Platform to Accelerate Biologics Development

Government aware of vape devices designed to bypass UK regulations, Lords told

Business Wire logo

Magentus Launches UK Advisory Board to Strengthen Clinical Diagnostics Strategy

ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT FEBRUARY 2026

PR Newswire associated0

XYRA Announces Issuance of US Patent to Reduce the Risk of Heart Failure or Strokes by Reducing the Number and Duration of Atrial Fibrillations

ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis

PR Newswire associated0

Bracco Imaging and Canon Medical Systems Europe Announce Joint Symposium on CEUS at ECR 2026

Advancing Influenza Vaccine Development: Sino Biological Launches Antigens for the 2026-2027 Northern Hemisphere Influenza Vaccine Strains

Two in Three Patients Hide Weight Loss Treatment, UK Study Finds

PR Newswire associated0

Antengene and UCB Enter Global License Agreement for ATG-201, a CD19/CD3 Bispecific T-Cell Engager for Autoimmune Diseases

PR Newswire associated0

Lyfegen Unveils Generative AI to Transform Drug Contracting and Accelerate Patient Access